PeerVoice Clinical Pharmacology Video

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 18m. Bisher sind 418 Folge(n) erschienen. Alle 3 Tage erscheint eine Folge dieses Podcasts.

Gesamtlänge aller Episoden: 6 days 9 hours 49 minutes

subscribe
share





Can Long-Acting Injectables Make a Difference in HIV?


Can Long-Acting Injectables Make a Difference in HIV?


share







   25m
 
 

Optimising Standard of Care for Patients With Axial Spondyloarthropathies: Why Gender Matters!


Optimising Standard of Care for Patients With Axial Spondyloarthropathies: Why Gender Matters!


share







   23m
 
 

Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure


Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure


share







   18m
 
 

Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes


Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes


share







 2021-03-12  13m
 
 

Prevention and Management of Cardiovascular Adverse Events in Multiple Myeloma: Safe and Appropriate Use of Proteasome Inhibitors


Prevention and Management of Cardiovascular Adverse Events in Multiple Myeloma: Safe and Appropriate Use of Proteasome Inhibitors


share







 2021-03-01  10m
 
 

Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments


Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments


share







 2021-02-24  16m
 
 

Basal Cell Carcinoma: Treatment Advances for the Progressing Patient


Basal Cell Carcinoma: Treatment Advances for the Progressing Patient


share







 2021-02-19  13m
 
 

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


share







 2021-02-17  19m
 
 

Seizing the Moment to Improve Outcomes in Melanoma: When and in Whom Should We Consider Adjuvant Therapy?


Seizing the Moment to Improve Outcomes in Melanoma: When and in Whom Should We Consider Adjuvant Therapy?


share







 2021-02-15  13m
 
 

The First Biologic in IBD: When, Which, and Why?


The First Biologic in IBD: When, Which, and Why?


share







 2021-02-12  30m